Johnson & JohnsonvsWest Pharmaceutical Services

JNJ and WST stock compared: price, dividend, valuation and results, from SEC filings.

WST

West Pharmaceutical Services, Inc.

$404.02

Value $29.1B

-2.44%
WST's page

Johnson & Johnson (JNJ) has a market value of $657B and West Pharmaceutical Services (WST) $29.1B. Over the last year, with dividends, JNJ moved +39.7% and WST +54.4%. The P/E is 40.8 for JNJ and 45.5 for WST. Dividend yield: JNJ 1.94%, WST 0.23%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$657B

    WST$29.1B

    JNJ is 23 times WST

  • Revenue, 12 months

    JNJ$99.3B

    WST$3.4B

    JNJ is 29 times WST

  • Net income, 12 months

    JNJ$16.1B

    WST$639M

    JNJ is 25 times WST

  • Operating margin

    JNJ–

    WST23.0%

  • ROIC

    JNJ12.4%

    WST19.0%

    6.6 points apart

  • P/E

    JNJ40.8

    WST45.5

    WST is 1.1 times JNJ

  • Dividend yield

    JNJ1.9%

    WST0.2%

    1.7 points apart

  • 5-year return

    JNJ+92.0%

    WST-7.9%

    99.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+92.0%

WST-7.9%

5010015020020222023202420252026
Returns by period
PeriodJNJWith dividendsWSTWith dividends
1 year since November 17, 2025+39.7%Price +36.6%+54.4%Price +54.0%
3 years since November 17, 2023+98.2%+25.6% a yearPrice +82.1%+18.9%+5.9% a yearPrice +17.9%
5 years since November 17, 2021+92.0%+13.9% a yearPrice +67.0%-7.9%-1.6% a yearPrice -9.1%
10 years since November 18, 2016+208.0%+11.9% a yearPrice +136.4%+422.3%+18.0% a yearPrice +404.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonWSTWest Pharmaceutical Services

Valuation

JNJWST
Valuation
Price$272.70$404.02
Market value$657B$29.1B
Enterprise value (EV)$685B$28.8B
P/E40.845.5
P/E, 5-year median21.944.7
P/B8.19.8
EV/EBIT38.637.0
Free cash flow yield3.1%1.6%

Results and growth

JNJWST
Results and growth
Revenue, 12 months$99.3B$3.4B
Net income, 12 months$16.1B$639M
Free cash flow, 12 months$20.6B$453M
Earnings per share, 12 months$6.59$8.91
Revenue growth, year on year6.1%6.3%
Revenue growth a year, past+2.7%over 5 years+7.4%over 5 years
EPS growth a year, past+14.9%over 5 years+8.2%over 5 years

Margins and returns on capital

JNJWST
Margins and returns on capital
Gross margin67.6%37.6%
Operating margin–23.0%
Net margin16.2%18.8%
ROIC12.4%19.0%
ROE19.7%21.1%

Balance sheet

JNJWST
Balance sheet
Cash$17.2B$464M
Total debt$44.7B$314M
Net debt / EBITDA1.1-0.3
Interest cover18.0×96.3×

Dividends and buybacks

JNJWST
Dividends and buybacks
Dividend yield1.9%0.2%
Dividend per share, 12 months$5.28$0.92
Dividend growth a year, past+5.3%over 5 years+5.4%over 5 years
Buyback yield0.9%0.5%
Shareholder yield2.9%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or WST

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or West Pharmaceutical Services?

By market value, Johnson & Johnson ($657B) is about 22.6 times West Pharmaceutical Services ($29.1B), at today's prices.

How did JNJ and WST stock do over the last 10 years?

Since November 18, 2016, JNJ's price moved +136.4% and WST's +404.1%. With dividends: JNJ +208.0% (+11.9% a year), WST +422.3% (+18.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or WST?

The dividend yield at today's price is 1.94% for Johnson & Johnson and 0.23% for West Pharmaceutical Services. Over the last twelve months they paid $5.28 and $0.92 per share.

What is the P/E of JNJ and WST?

At today's price, the P/E is 40.8 for JNJ and 45.5 for WST. The median of the last five years was 21.9 and 44.7, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or West Pharmaceutical Services?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 18.8% for West Pharmaceutical Services, and the operating margin – and 23.0%. Revenue was $99.3B and $3.4B.

Which is the better investment, Johnson & Johnson or West Pharmaceutical Services?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.